Eurofarma Laboratorios S.A.
Headquarters country
Brazil
Registry sponsor category
Industry
- Other names
- Eurofarma Laboratorios S.A.
- Company name
- Eurofarma Laboratorios S.A.
- Organisation type
- Industry
- Registered legal name
- EUROFARMA LABORATORIOS S.A.
- Registry sponsor category
- Industry
- Legal Entity Identifier (LEI)
- 254900GA8883LV1TXY07
Related records
Trials (66)
- A Clinical Trial About Treatment of Mild to Moderate Persistent Alergic Rhinnitis With Test or Reference Mometasone (PUMA)
- A Comparative Study Between Foraseq and Formoterol/Budesonide Inhalation Capsules in Patients with Asthma
- A Multicenter, Randomized, Parallel, Two-period, Non-inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment
- A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with Asthma
- A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer
- A Non-inferiority Study Comparing Two Heparin Sodium Preparations in Hip Fracture Surgery
- A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia
- A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma
- A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia
- A Non-inferiority, Multicenter and Randomized, Single-Dose Study About a Treatment to Hypolactasia (LAILAI)
- A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study
- A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight
- A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients
- A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer
- Assessment of EF192A Potential Sensitization and Accumulated and Primary Irritability in Controlled/Maximized Conditions
- Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL)
- Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at the Gastroesophageal Reflux Disease
- Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis
- Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis
- Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol